Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  28.00 1.84% 1,550.00 71,061 16:00:05
Bid Price Offer Price High Price Low Price Open Price
1,542.00 1,550.00 1,554.00 1,508.00 1,508.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.31 0.66 1.00 1,550.0 642
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:24 UT 63 1,550.00 GBX

Biotech Growth (BIOG) Latest News (1)

More Biotech Growth News
Biotech Growth Investors    Biotech Growth Takeover Rumours

Biotech Growth (BIOG) Discussions and Chat

Biotech Growth Forums and Chat

Date Time Title Posts
24/2/202122:53Biotech Growth Trust PLC (The)326

Add a New Thread

Biotech Growth (BIOG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-03-02 16:35:241,550.0063976.50UT
2021-03-02 16:27:331,549.561271,967.94O
2021-03-02 16:25:481,545.391942,998.06O
2021-03-02 16:24:411,549.567108.47O
2021-03-02 16:21:431,549.561271,967.94O
View all Biotech Growth trades in real-time

Biotech Growth (BIOG) Top Chat Posts

Biotech Growth Daily Update: Biotech Growth Trust (the) Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BIOG. The last closing price for Biotech Growth was 1,522p.
Biotech Growth Trust (the) Plc has a 4 week average price of 1,494p and a 12 week average price of 1,494p.
The 1 year high share price is 1,750p while the 1 year low share price is currently 680p.
There are currently 41,424,769 shares in issue and the average daily traded volume is 135,743 shares. The market capitalisation of Biotech Growth Trust (the) Plc is £642,083,919.50.
caradog: AstraZeneca to take over Alexion, which was BIOGs biggest holding on 31 Oct at 5.1% of the portfolio when Alexion’s share price was about $114. The cash and share deal is worth about $175 - a 45% premium on last quoted price.
healthtech: That's because IBT has a dividend yield of 4% and has outperformed its index. Seems like YTD BIOG is performing better, but need to sustain this to improve its long term performance.
rogerrail: IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point
andyj: Share price nearly 10% below NAV now, should see some buy backs.
andyj: By the way, there is an excellent and insightful free research paper on BIOG at Edison Investment Research dated Feb 22. Sorry I cannot post the link.
andyj: Thanks all, probably sound advice, just having a clear out of underperforming investments in my portfolio and noticed BIOG has consistently been a losing investment for me.
earthmanian: Now it's 10% discount to nav. Biog should now be buying their own shares back, let's see.....
earthmanian: Any ideas as to why the share is now trading around its NAV. For the last few years the share has been trading at a discount to its NAV of about 5% ?
earthmanian: So with Brexit and US Elections done and dusted, maybe a few months of mergers, acquisitions and cancer treatment successes can see this move quickly up to £8 especially now no government meddling in price structures. A great day!
redhill9: Large fall in share price this morning with a few sells. NAV at 867p suggests a discount now of around 13% compared to the more usual c.7%. Anyone any ideas on the reason for the drop in sp? I know BIOG share price can be a bit volatile but usually that's caused by similar movement in NAV.
Biotech Growth share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210303 03:28:39